cgp 20712a and metoprolol

cgp 20712a has been researched along with metoprolol in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (44.44)18.2507
2000's4 (44.44)29.6817
2010's1 (11.11)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Carrupt, PA; Gaillard, P; Schambel, P; Testa, B1
Iakovidis, D; Jackman, GP; Louis, SN; Louis, WJ; Nero, TL1
Amend, A; Candelore, MR; Cascieri, MA; Deng, L; Guan, XM; Liu, Y; Newbold, R; Tota, L; Weber, AE1
Baker, JG1
Duke, BJ; Jackman, GP; Louis, SN; Louis, WJ; Machida, CA; Nero, TL; Rezmann-Vitti, LA1
Carson, PE1
Bölck, B; Brixius, K; Bundkirchen, A; Mehlhorn, U; Schwinger, RH1
Christ, T; Kaumann, A; Molenaar, P; Ravens, U1
Bányász, T; Bárándi, L; Harmati, G; Horváth, B; Magyar, J; Nánási, PP; Szabó, G; Szénási, G; Szentandrássy, N; Szentmiklósi, JA1

Reviews

1 review(s) available for cgp 20712a and metoprolol

ArticleYear
Beta-blocker therapy in heart failure: pathophysiology and clinical results.
    Current problems in cardiology, 1999, Volume: 24, Issue:7

    Topics: Adrenergic beta-Antagonists; Aged; Bisoprolol; Carbazoles; Carvedilol; Clinical Trials as Topic; Exercise; Heart Failure; Heart Rate; Hemodynamics; Humans; Imidazoles; Male; Metoprolol; Middle Aged; Propanolamines; Propranolol; Quality of Life; Stroke Volume; Time Factors; Vasodilator Agents; Xamoterol

1999

Other Studies

8 other study(ies) available for cgp 20712a and metoprolol

ArticleYear
Binding of arylpiperazines, (aryloxy)propanolamines, and tetrahydropyridylindoles to the 5-HT1A receptor: contribution of the molecular lipophilicity potential to three-dimensional quantitative structure-affinity relationship models.
    Journal of medicinal chemistry, 1996, Jan-05, Volume: 39, Issue:1

    Topics: Indoles; Ligands; Models, Molecular; Molecular Conformation; Molecular Structure; Piperazines; Propanolamines; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Serotonin; Structure-Activity Relationship; Tetrahydronaphthalenes

1996
LK 204-545, a highly selective beta1-adrenoceptor antagonist at human beta-adrenoceptors.
    European journal of pharmacology, 1999, Feb-19, Volume: 367, Issue:2-3

    Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; CHO Cells; Cricetinae; Cyclopropanes; Female; Humans; Imidazoles; In Vitro Techniques; Ligands; Phenoxypropanolamines; Protein Binding; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, beta; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Trachea; Urea

1999
Potent and selective human beta(3)-adrenergic receptor antagonists.
    The Journal of pharmacology and experimental therapeutics, 1999, Volume: 290, Issue:2

    Topics: Adipocytes; Adrenergic beta-Antagonists; Aminophenols; Animals; Binding, Competitive; CHO Cells; Cloning, Molecular; Cricetinae; Cyclic AMP; Humans; Ligands; Lipolysis; Macaca mulatta; Receptors, Adrenergic, beta; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Receptors, Adrenergic, beta-3; Structure-Activity Relationship; Sulfonamides

1999
The selectivity of beta-adrenoceptor antagonists at the human beta1, beta2 and beta3 adrenoceptors.
    British journal of pharmacology, 2005, Volume: 144, Issue:3

    Topics: Adrenergic beta-1 Receptor Agonists; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-3 Receptor Agonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Algorithms; Animals; Cell Line; CHO Cells; Cricetinae; Dioxoles; Humans; Propanolamines; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Receptors, Adrenergic, beta-3

2005
Role of Tyr(356(7.43)) and Ser(190(4.57)) in antagonist binding in the rat beta1-adrenergic receptor.
    Journal of medicinal chemistry, 2006, Jun-15, Volume: 49, Issue:12

    Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-Antagonists; Animals; Binding Sites; Binding, Competitive; CHO Cells; Cricetinae; Cricetulus; Models, Molecular; Mutagenesis, Site-Directed; Propanolamines; Rats; Receptors, Adrenergic, beta-1; Serine; Stereoisomerism; Transfection; Tyrosine

2006
Nebivolol, bucindolol, metoprolol and carvedilol are devoid of intrinsic sympathomimetic activity in human myocardium.
    British journal of pharmacology, 2001, Volume: 133, Issue:8

    Topics: Adrenergic beta-Antagonists; Benzopyrans; Binding, Competitive; Bisoprolol; Carbazoles; Carvedilol; Ethanolamines; Female; Guanylyl Imidodiphosphate; Heart Ventricles; Humans; Imidazoles; In Vitro Techniques; Inhibitory Concentration 50; Isoproterenol; Male; Metoprolol; Middle Aged; Myocardial Contraction; Myocardium; Nebivolol; Propanolamines; Substrate Specificity; Sympathetic Nervous System; Sympathomimetics; Thermodynamics

2001
Carvedilol blocks beta2- more than beta1-adrenoceptors in human heart.
    Cardiovascular research, 2006, Volume: 69, Issue:1

    Topics: Adrenergic beta-Antagonists; Calcium Channels, L-Type; Carbazoles; Carvedilol; Dose-Response Relationship, Drug; Epinephrine; Heart Atria; Heart Failure; Heart Ventricles; Humans; Imidazoles; In Vitro Techniques; Metoprolol; Myocardial Contraction; Myocardium; Norepinephrine; Patch-Clamp Techniques; Propanolamines; Propranolol; Receptors, Adrenergic; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2

2006
Effects of β-adrenoceptor stimulation on delayed rectifier K(+) currents in canine ventricular cardiomyocytes.
    British journal of pharmacology, 2011, Volume: 162, Issue:4

    Topics: Action Potentials; Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-Agonists; Animals; Cells, Cultured; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Delayed Rectifier Potassium Channels; Dogs; Heart Ventricles; Imidazoles; Isoproterenol; Kinetics; Metoprolol; Myocytes, Cardiac; Patch-Clamp Techniques; Protein Kinase Inhibitors; Receptors, Adrenergic, beta-1; Signal Transduction; Single-Cell Analysis

2011